Home » Topics » BioWorld Science

BioWorld Science
RSS

BioMarin completes phase I clinical trials for rhASB

July 30, 2001

Positive opinion from EMEA moves Foscan closer to approval

July 30, 2001

Expanded use of Visudyne approved by Canadian authorities

July 30, 2001

Novel emphysema therapy receives orphan medicinal product designation

July 30, 2001

GSK and Shionogi to form joint venture for multiproduct development and commercialization

July 30, 2001

Nastech successfully delivers intranasal interferon alfa

July 30, 2001

Panacea awarded research grant for Parkinson's disease

July 30, 2001

Artecel Sciences awarded two SBIR grants for adipose tissue research

July 30, 2001

NIH licensing opportunity: genes related to prostate cancer

July 30, 2001

UPCI announces major effort in the area of lung cancer

July 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.